A prospective study of the use of central venous catheters in patients newly diagnosed with acute myeloid leukemia treated with induction chemotherapy
暂无分享,去创建一个
D. Normolle | D. Bovbjerg | R. Farah | A. Raptis | A. Im | K. Dorritie | M. Boyiadzis | R. Redner | Jingzhou Hou | A. Sehgal | J. Rossetti | M. Agha | K. Lontos | C. McKeown | Asha Ricciuti
[1] Yalou Pu,et al. Complications and Costs of Peripherally Inserted Central Venous Catheters Compared With Implantable Port Catheters for Cancer Patients , 2019, Cancer nursing.
[2] F. Pane,et al. A Frontline Approach With Peripherally Inserted Versus Centrally Inserted Central Venous Catheters for Remission Induction Chemotherapy Phase of Acute Myeloid Leukemia: A Randomized Comparison , 2019, Clinical lymphoma, myeloma & leukemia.
[3] C. Teng,et al. Application of peripherally inserted central catheter in acute myeloid leukaemia patients undergoing induction chemotherapy , 2017, European journal of cancer care.
[4] Naomi P O'Grady,et al. Prevention of Central Line-Associated Bloodstream Infections. , 2023, The New England journal of medicine.
[5] J. Brandwein,et al. Incidence of catheter-related thrombosis in acute leukemia patients: a comparative, retrospective study of the safety of peripherally inserted vs. centrally inserted central venous catheters , 2016, Annals of Hematology.
[6] Mario Cazzola,et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. , 2016, Blood.
[7] F. Cardoso,et al. Central venous access in oncology: ESMO Clinical Practice Guidelines. , 2015, Annals of oncology : official journal of the European Society for Medical Oncology.
[8] I. Raad,et al. Advances in prevention and management of central line-associated bloodstream infections in patients with cancer. , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[9] J. Holter,et al. Central Venous Catheter-Related Complications in acute Myeloid Leukemia Patients , 2014, Journal of Vascular Access.
[10] V. Chopra,et al. The Risk of Bloodstream Infection Associated with Peripherally Inserted Central Catheters Compared with Central Venous Catheters in Adults: A Systematic Review and Meta-Analysis , 2013, Infection Control & Hospital Epidemiology.
[11] S. Kaufmann,et al. Comparison of complication rates of Hickman® catheters versus peripherally inserted central catheters in patients with acute myeloid leukemia undergoing induction chemotherapy , 2013, Leukemia & lymphoma.
[12] M. Gorman,et al. Central venous catheter care for the patient with cancer: American Society of Clinical Oncology clinical practice guideline. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[13] S. Doucette,et al. Vascular access devices in leukemia: a retrospective review amongst patients treated at The Ottawa Hospital with induction chemotherapy for acute leukemia , 2012, Leukemia & lymphoma.
[14] Sanjay Saint,et al. Guidelines for the prevention of intravascular catheter-related infections. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[15] Vital signs: central line-associated blood stream infections--United States, 2001, 2008, and 2009. , 2011, MMWR. Morbidity and mortality weekly report.
[16] M. Björkholm,et al. Patients’ perceptions of having a central venous catheter or a totally implantable subcutaneous port system–results from a randomised study in acute leukaemia , 2009, Supportive Care in Cancer.
[17] A. Bodenham,et al. Guidelines on the insertion and management of central venous access devices in adults , 2007, International journal of laboratory hematology.
[18] A. Loh,et al. Port-A-Cath insertions in acute leukemia: does thrombocytopenia affect morbidity? , 2007, Journal of pediatric surgery.
[19] R. Takolander,et al. Totally implantable subcutaneous port system versus central venous catheter placed before induction chemotherapy in patients with acute leukaemia—a randomized study , 2004, Supportive Care in Cancer.
[20] G. Lambertenghi-Deliliers,et al. Central Venous Catheter-related Complications in Patients with Hematological Malignancies: A Retrospective Analysis of Risk Factors and Prophylactic Measures , 2003, Leukemia & lymphoma.
[21] I. Lossos,et al. Vascular Access via Peripherally Inserted Central Venous Catheters (PICCs): Experience in 40 Patients with Acute Myeloid Leukemia at a Single Institute , 2001, Leukemia & lymphoma.